世界のインフルエンザAウイルス、H3N2サブタイプ感染薬市場

QYResearchが発行した調査報告書(DATA909X09790)
◆英語タイトル:Global Influenza A Virus, H3N2 Subtype Infections Drug Market Professional Survey Report 2019
◆商品コード:DATA909X09790
◆発行会社(リサーチ会社):QYResearch
◆発行日:2019年11月20日(※2024年版があります。お問い合わせください)
◆ページ数:113
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品・ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥518,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,250 ⇒換算¥777,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,000 ⇒換算¥1,036,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートは、インフルエンザAウイルス、H3N2サブタイプ感染薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、NEO-8877、NP-025、NSC-61610、NVINF-1、その他に、用途別には、クリニック、病院、その他にセグメント区分し、インフルエンザAウイルス、H3N2サブタイプ感染薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・インフルエンザAウイルス、H3N2サブタイプ感染薬の世界市場概要
・インフルエンザAウイルス、H3N2サブタイプ感染薬の製造コスト構成分析
・インフルエンザAウイルス、H3N2サブタイプ感染薬の開発・製造工場分析
・主要メーカーの主な指標(生産能力、売上、価格分析)
・インフルエンザAウイルス、H3N2サブタイプ感染薬の地域別分析(生産、売上、主要メーカー、輸出・輸入)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・インフルエンザAウイルス、H3N2サブタイプ感染薬のセグメント分析(種類別)
(NEO-8877、NP-025、NSC-61610、NVINF-1、その他)
・インフルエンザAウイルス、H3N2サブタイプ感染薬のセグメント分析(用途別)
(クリニック、病院、その他)
・インフルエンザAウイルス、H3N2サブタイプ感染薬の主要メーカー別分析(生産拠点、製品概要、生産・売上実績)
(AbbVie Inc、AIMM Therapeutics B.V.、Aphios Corporation、Celltrion, Inc.、FluGen, Inc.、Glide Pharmaceutical Technologies Limited、ILiAD Biotechnologies, LLC、Inovio Pharmaceuticals, Inc.、Johnson & Johnson、Medicago Inc.、MedImmune, LLC、Mucosis B.V.、NanoViricides, Inc.、OPKO Health, Inc.、Sarepta Therapeutics, Inc.、VBI Vaccines Inc.、Visterra, Inc.、Zydus Cadila Healthcare Limited、)
・インフルエンザAウイルス、H3N2サブタイプ感染薬の市場規模予測(2019年~2025年)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス(市場動向、機会、成長要因、課題、影響因子)
...
【レポートの概要】

The global Influenza A Virus, H3N2 Subtype Infections Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Influenza A Virus, H3N2 Subtype Infections Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Influenza A Virus, H3N2 Subtype Infections Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Influenza A Virus, H3N2 Subtype Infections Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Influenza A Virus, H3N2 Subtype Infections Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
AbbVie Inc
AIMM Therapeutics B.V.
Aphios Corporation
Celltrion, Inc.
FluGen, Inc.
Glide Pharmaceutical Technologies Limited
ILiAD Biotechnologies, LLC
Inovio Pharmaceuticals, Inc.
Johnson & Johnson
Medicago Inc.
MedImmune, LLC
Mucosis B.V.
NanoViricides, Inc.
OPKO Health, Inc.
Sarepta Therapeutics, Inc.
VBI Vaccines Inc.
Visterra, Inc.
Zydus Cadila Healthcare Limited

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
NEO-8877
NP-025
NSC-61610
NVINF-1
Others

Segment by Application
Clinic
Hospital
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Influenza A Virus, H3N2 Subtype Infections Drug
1.1 Definition of Influenza A Virus, H3N2 Subtype Infections Drug
1.2 Influenza A Virus, H3N2 Subtype Infections Drug Segment by Type
1.2.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 NEO-8877
1.2.3 NP-025
1.2.4 NSC-61610
1.2.5 NVINF-1
1.2.6 Others
1.3 Influenza A Virus, H3N2 Subtype Infections Drug Segment by Applications
1.3.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Influenza A Virus, H3N2 Subtype Infections Drug Overall Market
1.4.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue (2014-2025)
1.4.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Production (2014-2025)
1.4.3 North America Influenza A Virus, H3N2 Subtype Infections Drug Status and Prospect (2014-2025)
1.4.4 Europe Influenza A Virus, H3N2 Subtype Infections Drug Status and Prospect (2014-2025)
1.4.5 China Influenza A Virus, H3N2 Subtype Infections Drug Status and Prospect (2014-2025)
1.4.6 Japan Influenza A Virus, H3N2 Subtype Infections Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Influenza A Virus, H3N2 Subtype Infections Drug Status and Prospect (2014-2025)
1.4.8 India Influenza A Virus, H3N2 Subtype Infections Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Influenza A Virus, H3N2 Subtype Infections Drug
2.3 Manufacturing Process Analysis of Influenza A Virus, H3N2 Subtype Infections Drug
2.4 Industry Chain Structure of Influenza A Virus, H3N2 Subtype Infections Drug

3 Development and Manufacturing Plants Analysis of Influenza A Virus, H3N2 Subtype Infections Drug
3.1 Capacity and Commercial Production Date
3.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Influenza A Virus, H3N2 Subtype Infections Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Influenza A Virus, H3N2 Subtype Infections Drug Production and Capacity Analysis
4.2 Influenza A Virus, H3N2 Subtype Infections Drug Revenue Analysis
4.3 Influenza A Virus, H3N2 Subtype Infections Drug Price Analysis
4.4 Market Concentration Degree

5 Influenza A Virus, H3N2 Subtype Infections Drug Regional Market Analysis
5.1 Influenza A Virus, H3N2 Subtype Infections Drug Production by Regions
5.1.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Production by Regions
5.1.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Regions
5.2 Influenza A Virus, H3N2 Subtype Infections Drug Consumption by Regions
5.3 North America Influenza A Virus, H3N2 Subtype Infections Drug Market Analysis
5.3.1 North America Influenza A Virus, H3N2 Subtype Infections Drug Production
5.3.2 North America Influenza A Virus, H3N2 Subtype Infections Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Influenza A Virus, H3N2 Subtype Infections Drug Import and Export
5.4 Europe Influenza A Virus, H3N2 Subtype Infections Drug Market Analysis
5.4.1 Europe Influenza A Virus, H3N2 Subtype Infections Drug Production
5.4.2 Europe Influenza A Virus, H3N2 Subtype Infections Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Influenza A Virus, H3N2 Subtype Infections Drug Import and Export
5.5 China Influenza A Virus, H3N2 Subtype Infections Drug Market Analysis
5.5.1 China Influenza A Virus, H3N2 Subtype Infections Drug Production
5.5.2 China Influenza A Virus, H3N2 Subtype Infections Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Influenza A Virus, H3N2 Subtype Infections Drug Import and Export
5.6 Japan Influenza A Virus, H3N2 Subtype Infections Drug Market Analysis
5.6.1 Japan Influenza A Virus, H3N2 Subtype Infections Drug Production
5.6.2 Japan Influenza A Virus, H3N2 Subtype Infections Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Influenza A Virus, H3N2 Subtype Infections Drug Import and Export
5.7 Southeast Asia Influenza A Virus, H3N2 Subtype Infections Drug Market Analysis
5.7.1 Southeast Asia Influenza A Virus, H3N2 Subtype Infections Drug Production
5.7.2 Southeast Asia Influenza A Virus, H3N2 Subtype Infections Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Influenza A Virus, H3N2 Subtype Infections Drug Import and Export
5.8 India Influenza A Virus, H3N2 Subtype Infections Drug Market Analysis
5.8.1 India Influenza A Virus, H3N2 Subtype Infections Drug Production
5.8.2 India Influenza A Virus, H3N2 Subtype Infections Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Influenza A Virus, H3N2 Subtype Infections Drug Import and Export

6 Influenza A Virus, H3N2 Subtype Infections Drug Segment Market Analysis (by Type)
6.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Production by Type
6.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Type
6.3 Influenza A Virus, H3N2 Subtype Infections Drug Price by Type

7 Influenza A Virus, H3N2 Subtype Infections Drug Segment Market Analysis (by Application)
7.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Consumption by Application
7.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Consumption Market Share by Application (2014-2019)

8 Influenza A Virus, H3N2 Subtype Infections Drug Major Manufacturers Analysis
8.1 AbbVie Inc
8.1.1 AbbVie Inc Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served
8.1.2 AbbVie Inc Product Introduction, Application and Specification
8.1.3 AbbVie Inc Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 AIMM Therapeutics B.V.
8.2.1 AIMM Therapeutics B.V. Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served
8.2.2 AIMM Therapeutics B.V. Product Introduction, Application and Specification
8.2.3 AIMM Therapeutics B.V. Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Aphios Corporation
8.3.1 Aphios Corporation Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served
8.3.2 Aphios Corporation Product Introduction, Application and Specification
8.3.3 Aphios Corporation Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Celltrion, Inc.
8.4.1 Celltrion, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served
8.4.2 Celltrion, Inc. Product Introduction, Application and Specification
8.4.3 Celltrion, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 FluGen, Inc.
8.5.1 FluGen, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served
8.5.2 FluGen, Inc. Product Introduction, Application and Specification
8.5.3 FluGen, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Glide Pharmaceutical Technologies Limited
8.6.1 Glide Pharmaceutical Technologies Limited Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served
8.6.2 Glide Pharmaceutical Technologies Limited Product Introduction, Application and Specification
8.6.3 Glide Pharmaceutical Technologies Limited Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 ILiAD Biotechnologies, LLC
8.7.1 ILiAD Biotechnologies, LLC Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served
8.7.2 ILiAD Biotechnologies, LLC Product Introduction, Application and Specification
8.7.3 ILiAD Biotechnologies, LLC Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Inovio Pharmaceuticals, Inc.
8.8.1 Inovio Pharmaceuticals, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served
8.8.2 Inovio Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.8.3 Inovio Pharmaceuticals, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Johnson & Johnson
8.9.1 Johnson & Johnson Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served
8.9.2 Johnson & Johnson Product Introduction, Application and Specification
8.9.3 Johnson & Johnson Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Medicago Inc.
8.10.1 Medicago Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served
8.10.2 Medicago Inc. Product Introduction, Application and Specification
8.10.3 Medicago Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 MedImmune, LLC
8.12 Mucosis B.V.
8.13 NanoViricides, Inc.
8.14 OPKO Health, Inc.
8.15 Sarepta Therapeutics, Inc.
8.16 VBI Vaccines Inc.
8.17 Visterra, Inc.
8.18 Zydus Cadila Healthcare Limited

9 Development Trend of Analysis of Influenza A Virus, H3N2 Subtype Infections Drug Market
9.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Market Trend Analysis
9.1.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Influenza A Virus, H3N2 Subtype Infections Drug Regional Market Trend
9.2.1 North America Influenza A Virus, H3N2 Subtype Infections Drug Forecast 2019-2025
9.2.2 Europe Influenza A Virus, H3N2 Subtype Infections Drug Forecast 2019-2025
9.2.3 China Influenza A Virus, H3N2 Subtype Infections Drug Forecast 2019-2025
9.2.4 Japan Influenza A Virus, H3N2 Subtype Infections Drug Forecast 2019-2025
9.2.5 Southeast Asia Influenza A Virus, H3N2 Subtype Infections Drug Forecast 2019-2025
9.2.6 India Influenza A Virus, H3N2 Subtype Infections Drug Forecast 2019-2025
9.3 Influenza A Virus, H3N2 Subtype Infections Drug Market Trend (Product Type)
9.4 Influenza A Virus, H3N2 Subtype Infections Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Influenza A Virus, H3N2 Subtype Infections Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Influenza A Virus, H3N2 Subtype Infections Drug
Table Global Influenza A Virus, H3N2 Subtype Infections Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Influenza A Virus, H3N2 Subtype Infections Drug Production Market Share by Types in 2018
Figure NEO-8877 Product Picture
Figure NP-025 Product Picture
Figure NSC-61610 Product Picture
Figure NVINF-1 Product Picture
Figure Others Product Picture
Table Global Influenza A Virus, H3N2 Subtype Infections Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Influenza A Virus, H3N2 Subtype Infections Drug Consumption Market Share by Applications in 2018
Figure Clinic
Figure Hospital
Figure Others
Figure Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue (Million USD) (2014-2025)
Figure Global Influenza A Virus, H3N2 Subtype Infections Drug Production (K Pcs) (2014-2025)
Figure North America Influenza A Virus, H3N2 Subtype Infections Drug Market Size (Million USD) (2014-2025)
Figure Europe Influenza A Virus, H3N2 Subtype Infections Drug Market Size (Million USD) (2014-2025)
Figure China Influenza A Virus, H3N2 Subtype Infections Drug Market Size (Million USD) (2014-2025)
Figure Japan Influenza A Virus, H3N2 Subtype Infections Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Influenza A Virus, H3N2 Subtype Infections Drug Market Size (Million USD) (2014-2025)
Figure India Influenza A Virus, H3N2 Subtype Infections Drug Market Size (Million USD) (2014-2025)
Table Influenza A Virus, H3N2 Subtype Infections Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Influenza A Virus, H3N2 Subtype Infections Drug in 2018
Figure Manufacturing Process Analysis of Influenza A Virus, H3N2 Subtype Infections Drug
Figure Industry Chain Structure of Influenza A Virus, H3N2 Subtype Infections Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Influenza A Virus, H3N2 Subtype Infections Drug Manufacturing Plants Distribution
Table Influenza A Virus, H3N2 Subtype Infections Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Influenza A Virus, H3N2 Subtype Infections Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Influenza A Virus, H3N2 Subtype Infections Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Influenza A Virus, H3N2 Subtype Infections Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Influenza A Virus, H3N2 Subtype Infections Drug Production Share by Manufacturers in 2018
Table Influenza A Virus, H3N2 Subtype Infections Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Influenza A Virus, H3N2 Subtype Infections Drug Revenue Share by Manufacturers in 2018
Table Influenza A Virus, H3N2 Subtype Infections Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Influenza A Virus, H3N2 Subtype Infections Drug Production by Regions 2014-2019 (K Pcs)
Table Global Influenza A Virus, H3N2 Subtype Infections Drug Production Market Share by Regions 2014-2019
Figure Global Influenza A Virus, H3N2 Subtype Infections Drug Production Market Share by Regions in 2018
Table Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share by Regions 2014-2019
Figure Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share by Regions in 2018
Table Global Influenza A Virus, H3N2 Subtype Infections Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Influenza A Virus, H3N2 Subtype Infections Drug Consumption Market Share by Regions 2014-2019
Figure North America Influenza A Virus, H3N2 Subtype Infections Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Influenza A Virus, H3N2 Subtype Infections Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Influenza A Virus, H3N2 Subtype Infections Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Influenza A Virus, H3N2 Subtype Infections Drug Production, Consumption Import and Export (K Pcs)
Figure China Influenza A Virus, H3N2 Subtype Infections Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Influenza A Virus, H3N2 Subtype Infections Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Influenza A Virus, H3N2 Subtype Infections Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Influenza A Virus, H3N2 Subtype Infections Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Influenza A Virus, H3N2 Subtype Infections Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Influenza A Virus, H3N2 Subtype Infections Drug Production, Consumption Import and Export (K Pcs)
Figure India Influenza A Virus, H3N2 Subtype Infections Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Influenza A Virus, H3N2 Subtype Infections Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Influenza A Virus, H3N2 Subtype Infections Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Influenza A Virus, H3N2 Subtype Infections Drug Market Share by Application (2014-2019)
Table AbbVie Inc Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served
Table AbbVie Inc Influenza A Virus, H3N2 Subtype Infections Drug Product Introduction, Application and Specification
Table AbbVie Inc Influenza A Virus, H3N2 Subtype Infections Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table AbbVie Inc Influenza A Virus, H3N2 Subtype Infections Drug Production Growth Rate (2014-2019)
Table AbbVie Inc Influenza A Virus, H3N2 Subtype Infections Drug Production Market Share (2014-2019)
Figure AbbVie Inc Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share (2014-2019)
Table AbbVie Inc Influenza A Virus, H3N2 Subtype Infections Drug Main Business and Markets Served
Table AIMM Therapeutics B.V. Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served
Table AIMM Therapeutics B.V. Influenza A Virus, H3N2 Subtype Infections Drug Product Introduction, Application and Specification
Table AIMM Therapeutics B.V. Influenza A Virus, H3N2 Subtype Infections Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table AIMM Therapeutics B.V. Influenza A Virus, H3N2 Subtype Infections Drug Production Growth Rate (2014-2019)
Table AIMM Therapeutics B.V. Influenza A Virus, H3N2 Subtype Infections Drug Production Market Share (2014-2019)
Figure AIMM Therapeutics B.V. Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share (2014-2019)
Table AIMM Therapeutics B.V. Influenza A Virus, H3N2 Subtype Infections Drug Main Business and Markets Served
Table Aphios Corporation Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served
Table Aphios Corporation Influenza A Virus, H3N2 Subtype Infections Drug Product Introduction, Application and Specification
Table Aphios Corporation Influenza A Virus, H3N2 Subtype Infections Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Aphios Corporation Influenza A Virus, H3N2 Subtype Infections Drug Production Growth Rate (2014-2019)
Table Aphios Corporation Influenza A Virus, H3N2 Subtype Infections Drug Production Market Share (2014-2019)
Figure Aphios Corporation Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share (2014-2019)
Table Aphios Corporation Influenza A Virus, H3N2 Subtype Infections Drug Main Business and Markets Served
Table Celltrion, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served
Table Celltrion, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Product Introduction, Application and Specification
Table Celltrion, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Celltrion, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production Growth Rate (2014-2019)
Table Celltrion, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production Market Share (2014-2019)
Figure Celltrion, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share (2014-2019)
Table Celltrion, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Main Business and Markets Served
Table FluGen, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served
Table FluGen, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Product Introduction, Application and Specification
Table FluGen, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table FluGen, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production Growth Rate (2014-2019)
Table FluGen, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production Market Share (2014-2019)
Figure FluGen, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share (2014-2019)
Table FluGen, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Main Business and Markets Served
Table Glide Pharmaceutical Technologies Limited Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served
Table Glide Pharmaceutical Technologies Limited Influenza A Virus, H3N2 Subtype Infections Drug Product Introduction, Application and Specification
Table Glide Pharmaceutical Technologies Limited Influenza A Virus, H3N2 Subtype Infections Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Glide Pharmaceutical Technologies Limited Influenza A Virus, H3N2 Subtype Infections Drug Production Growth Rate (2014-2019)
Table Glide Pharmaceutical Technologies Limited Influenza A Virus, H3N2 Subtype Infections Drug Production Market Share (2014-2019)
Figure Glide Pharmaceutical Technologies Limited Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share (2014-2019)
Table Glide Pharmaceutical Technologies Limited Influenza A Virus, H3N2 Subtype Infections Drug Main Business and Markets Served
Table ILiAD Biotechnologies, LLC Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served
Table ILiAD Biotechnologies, LLC Influenza A Virus, H3N2 Subtype Infections Drug Product Introduction, Application and Specification
Table ILiAD Biotechnologies, LLC Influenza A Virus, H3N2 Subtype Infections Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table ILiAD Biotechnologies, LLC Influenza A Virus, H3N2 Subtype Infections Drug Production Growth Rate (2014-2019)
Table ILiAD Biotechnologies, LLC Influenza A Virus, H3N2 Subtype Infections Drug Production Market Share (2014-2019)
Figure ILiAD Biotechnologies, LLC Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share (2014-2019)
Table ILiAD Biotechnologies, LLC Influenza A Virus, H3N2 Subtype Infections Drug Main Business and Markets Served
Table Inovio Pharmaceuticals, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served
Table Inovio Pharmaceuticals, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Product Introduction, Application and Specification
Table Inovio Pharmaceuticals, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Inovio Pharmaceuticals, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production Growth Rate (2014-2019)
Table Inovio Pharmaceuticals, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production Market Share (2014-2019)
Figure Inovio Pharmaceuticals, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share (2014-2019)
Table Inovio Pharmaceuticals, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Main Business and Markets Served
Table Johnson & Johnson Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served
Table Johnson & Johnson Influenza A Virus, H3N2 Subtype Infections Drug Product Introduction, Application and Specification
Table Johnson & Johnson Influenza A Virus, H3N2 Subtype Infections Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Johnson & Johnson Influenza A Virus, H3N2 Subtype Infections Drug Production Growth Rate (2014-2019)
Table Johnson & Johnson Influenza A Virus, H3N2 Subtype Infections Drug Production Market Share (2014-2019)
Figure Johnson & Johnson Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share (2014-2019)
Table Johnson & Johnson Influenza A Virus, H3N2 Subtype Infections Drug Main Business and Markets Served
Table Medicago Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served
Table Medicago Inc. Influenza A Virus, H3N2 Subtype Infections Drug Product Introduction, Application and Specification
Table Medicago Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Medicago Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production Growth Rate (2014-2019)
Table Medicago Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production Market Share (2014-2019)
Figure Medicago Inc. Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share (2014-2019)
Table Medicago Inc. Influenza A Virus, H3N2 Subtype Infections Drug Main Business and Markets Served
Table MedImmune, LLC Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served
Table Mucosis B.V. Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served
Table NanoViricides, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served
Table OPKO Health, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served
Table Sarepta Therapeutics, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served
Table VBI Vaccines Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served
Table Visterra, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served
Table Zydus Cadila Healthcare Limited Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served
Figure Global Influenza A Virus, H3N2 Subtype Infections Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Influenza A Virus, H3N2 Subtype Infections Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Influenza A Virus, H3N2 Subtype Infections Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Influenza A Virus, H3N2 Subtype Infections Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Influenza A Virus, H3N2 Subtype Infections Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Influenza A Virus, H3N2 Subtype Infections Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Influenza A Virus, H3N2 Subtype Infections Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Influenza A Virus, H3N2 Subtype Infections Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Influenza A Virus, H3N2 Subtype Infections Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Influenza A Virus, H3N2 Subtype Infections Drug by Application (2019-2025)
Table Influenza A Virus, H3N2 Subtype Infections Drug Distributors List
Table Influenza A Virus, H3N2 Subtype Infections Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

AbbVie Inc、AIMM Therapeutics B.V.、Aphios Corporation、Celltrion, Inc.、FluGen, Inc.、Glide Pharmaceutical Technologies Limited、ILiAD Biotechnologies, LLC、Inovio Pharmaceuticals, Inc.、Johnson & Johnson、Medicago Inc.、MedImmune, LLC、Mucosis B.V.、NanoViricides, Inc.、OPKO Health, Inc.、Sarepta Therapeutics, Inc.、VBI Vaccines Inc.、Visterra, Inc.、Zydus Cadila Healthcare Limited、

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のインフルエンザAウイルス、H3N2サブタイプ感染薬市場(Global Influenza A Virus, H3N2 Subtype Infections Drug Market Professional Survey Report 2019)]についてメールでお問い合わせはこちらでお願いします。